MAPT and Alzheimer disease: Impaired insulin signaling in the brain disrupts glucose metabolism, synaptic function, and neuronal survival, contributing to hallmark AD pathologies, such as tau hyperphosphorylation, amyloid β accumulation, and neuroinflammation [36].